Home›Trial›NCT06873789
🔬NCT06873789Phase 1Phase 2ACTIVE NOT RECRUITING

A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors

Study Summary

This study will be conducted to evaluate INCB177054 given as monotherapy or in combination with retifanlimab in participants with select advanced or metastatic solid Tumors.

Conditions
Solid TumorsAdvanced Solid TumorsMetastatic Solid Tumors
Interventions / Drugs
INCB177054Retifanlimab
View on ClinicalTrials.gov ↗
Sponsor
INCY
Incyte Corporation
Oncology
C60/100
Study Details
Enrollment9 participants
Primary Completion—
Lead SponsorIncyte Corporation
Data Retrieved2026-04-11 02:55:29.647347+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.